Litcius/Paper detail

Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial

Anna Redl, Konstantin Doberer, Luisa Unterluggauer, Lisa Kleißl, Christoph Krall, Carolina Mayerhofer, Bärbel Reininger, Victoria Stary, Nina Zila, Wolfgang J. Weninger, Thomas Weichhart, Christoph Bock, Thomas Krausgruber, Georg Stary

2024The Lancet Rheumatology49 citationsDOI

Topics & Concepts

MedicineSarcoidosisSirolimusAdverse effectPlaceboClinical endpointDermatologyCutaneous SarcoidosisInternal medicineRandomized controlled trialClinical trialGastroenterologyPathologyAlternative medicineSarcoidosis and Beryllium Toxicity ResearchHistiocytic Disorders and TreatmentsTuberous Sclerosis Complex Research